Cancer Stem Cell News Volume 13.20 | Aug 21 2024

    0
    25








    2024-08-21 | CSCN 13.20


    Cancer Stem Cell News by STEMCELL Technologies
    Vol. 13.20 – 21 August, 2024
    TOP STORY

    The Peptidoglycan Recognition Protein 1 Confers Immune Evasive Properties on Pancreatic Cancer Stem Cells

    Researchers used a mouse model and primary tumor cell lines to investigate putative CSC populations. They established peptidoglycan recognition protein 1 as a novel CSC-associated marker crucial for immune evasion.
    [Gut]

    Full Article
    Explore this validated protocol for high-efficiency gene editing of Human Pluripotent Stem Cells using the ArciTect™ CRISPR-Cas9 System.
    PUBLICATIONSListed by the impact factor of the journal

    Identifying Key Circulating Tumor DNA Parameters for Predicting Clinical Outcomes in Metastatic Non-Squamous Non-Small Cell Lung Cancer After First-Line Chemoimmunotherapy

    Data from the large Phase III IMpower150 study of atezolizumab in combination with chemotherapy with or without bevacizumab in patients with stage IV non-squamous Non-Small Cell Lung Cancer suggested that post-treatment circulating tumor DNA response correlated significantly with radiographic response.
    [Nature Communications]

    Full Article

    Autophagy-Mediated ID1 Turnover Dictates Chemo-Resistant Fate in Ovarian Cancer Stem Cells

    Researchers investigated the role of targeted autophagic protein degradation in regulating ovarian CSC fate decisions and chemo-resistance.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    M2-Like Tumor-Associated Macrophage-Secreted CCL2 Facilitates Gallbladder Cancer Stemness and Metastasis

    Immunohistochemistry was used to evaluate the expression of M2-like tumor-associated macrophages and CSC markers in 24 pairs of gallbladder cancer and adjacent noncancerous tissues from patients with GBC.
    [Experimental Hematology & Oncology]

    Full Article

    Orai1 and Orai3 Act through Distinct Signaling Axes to Promote Stemness and Tumorigenicity of Breast Cancer Stem Cells

    A highly effective 3D soft fibrin gel system was used to enrich breast cancer stem cells-like cells from ER+ breast cancer lines MCF7 and MDA-MB-415.
    [Stem Cell Research & Therapy]

    Full Article

    Cancer Stemness Online: A Resource for Investigating Cancer Stemness and Associations with Immune Response

    The authors present the Cancer Stemness Online, an integrated resource for efficiently scoring cancer stemness potential at the bulk and single-cell levels. The resource integrates eight robust predictive algorithms as well as 27 signature gene sets associated with cancer stemness for predicting stemness scores.
    [Genomics Proteomics & Bioinformatics]

    Abstract

    Frizzled 6 Endows High-Grade Serous Ovarian Cancer With Stem-Like Properties and Chemoresistance

    FZD6 promoted high-grade serous ovarian cancer (HGSOC) growth and peritoneal metastasis. It endued HGSOC cells with stem-like properties by modulating POU5F1, ALDH1, and EPCAM. It could also desensitize HGSOC cells to certain chemical drugs.
    [Molecular Carcinogenesis]

    Abstract

    Oncogenic Fusion of CD63-BCAR4 Contributes Cancer Stem Cell-Like Properties via ALDH1 Activity

    Researchers investigated the CSC-like properties induced by CD63-BCAR4 fusion gene, previously reported as an oncogenic fusion, and its potential contribution for the enhanced metastasis as a notable characteristic of CD63-BCAR4.
    [Molecular Carcinogenesis]

    Full Article

    CHD4 R975H Mutant Activates Tumorigenic Pathways and Promotes Stemness and M2-Like Macrophage Polarization in Endometrial Cancer

    Investigators identified the CHD4 R975H mutation as a high-frequency occurrence in endometrial cancer (EC) patients through a comprehensive survey of EC databases.
    [Scientific Reports]

    Full Article
    Request a free copy of this wallchart for a quick reference on breast cancer subtypes and signaling pathways.
    REVIEWS

    Therapeutic Advances of Targeting Receptor Tyrosine Kinases in Cancer

    By integrating the latest research findings and clinical evidence, scientists seek to elucidate the pivotal role of receptor tyrosine kinases (RTKs) in cancer biology and the therapeutic efficacy of RTK inhibition with promising treatment outcomes.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Multidimensional Analysis of Tumor Stem Cells: From Biological Properties, Metabolic Adaptations to Immune Escape Mechanisms

    CSCs are able to maintain their stemness by regulating the metabolic networks to maintain their stemness characteristics, enhance antioxidant defences, and adapt to therapeutic stress.
    [Frontiers In Cell and Developmental Biology]

    Full Article
    INDUSTRY AND POLICY NEWS

    President Biden Announces $150 Million in Research Grants for Cancer “Moonshot” Initiative

    President Joe Biden took a break from the Elect Harris campaign trail, to advance policy goals close to his heart – the administration’s “moonshot” initiative to dramatically reduce cancer deaths.
    [The Lens]

    Press Release

    BioNTech Says FDA Lifts Partial Hold on Its Cancer Drug Trial

    BioNTech said the FDA has lifted a partial clinical hold on an early-stage study of its experimental cancer drug.
    [Reuters]

    Press Release

    $18M ARPA-H Award Supports Rice-Led Research on Tumor Analysis System for Breast, Head, and Neck Cancer

    A Rice University-led multi-institutional research collaboration has won an award of up to $18 million over five years from the Advanced Research Projects Agency for Health to develop and validate a new system for improving tumor removal accuracy for two types of cancer: breast, and head and neck cancer.
    [Rice University]

    Full Article
    FEATURED EVENT

    Defining and Defeating Metastasis

    September 30-October 03, 2024
    Heidelberg, Germany & Online

    > See All Events

    JOB OPPORTUNITIES

    Fellow – Melanoma and Surgical Oncology

    Melanoma Institute Australia – Wollstonecraft, North Sydney, Australia

    Project Manager – Clinical Research Trials

    BC Provincial Health Services Authority – Vancouver, British Columbia, Canada

    Doctoral Researcher – Computational Cancer of ECM-Hypoxia

    University of Oulu – Oulu, Finland

    Postdoctoral Position – Interdisciplinary Pediatric Cancer Genomics

    St. Anna Children’s Cancer Research Institute – Vienna, Austria

    Post Doc – Precision Oncology of Gastrointestinal Cancers

    City of Hope – Monrovia, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2